These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25910501)

  • 41. Gastrointestinal and Intracranial Bleeding Events After Second-Generation Drug-Eluting Stent Implantation　- Their Association With High Bleeding Risk, Predictors, and Clinical Outcomes.
    Taguchi Y; Miura K; Shima Y; Okabe K; Ikuta A; Takahashi K; Osakada K; Takamatsu M; Ohya M; Shimada T; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    Circ J; 2022 Apr; 86(5):775-783. PubMed ID: 35095086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.
    Cassese S; Byrne RA; Tada T; King LA; Kastrati A
    Eur Heart J; 2012 Dec; 33(24):3078-87. PubMed ID: 23091199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry).
    Mennuni MG; Halperin JL; Bansilal S; Schoos MM; Theodoropoulos KN; Meelu OA; Sartori S; Giacoppo D; Bernelli C; Moreno PR; Krishnan P; Baber U; Lucarelli C; Dangas GD; Sharma SK; Kini AS; Tamburino C; Chieffo A; Colombo A; Presbitero P; Mehran R
    Am J Cardiol; 2015 Jul; 116(1):37-42. PubMed ID: 25956624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting long-term bleeding after percutaneous coronary intervention.
    Sharma PK; Chhatriwalla AK; Cohen DJ; Jang JS; Baweja P; Gosch K; Jones P; Bach RG; Arnold SV; Spertus JA
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):199-206. PubMed ID: 27037854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bleeding Severity After Percutaneous Coronary Intervention.
    Redfors B; Généreux P; Witzenbichler B; Kirtane AJ; McAndrew T; Weisz G; Stuckey TD; Henry TD; Maehara A; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005542. PubMed ID: 29870382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Procedure-related bleeding in elective percutaneous coronary interventions.
    Ndrepepa G; Stephan T; Fiedler KA; Guerra E; Kufner S; Kastrati A
    Eur J Clin Invest; 2015 Mar; 45(3):263-73. PubMed ID: 25645583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).
    Dasari TW; Cohen DJ; Kleiman NS; Keyes MJ; Yen CH; Hanna EB; Saucedo JF
    Am J Cardiol; 2014 Feb; 113(4):621-5. PubMed ID: 24342762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of peripheral vascular disease on short- and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent era.
    Midwall S; Swaminathan RV; Charitakis K; Kim LK; Gordin J; Hriljac I; Minutello RM; Bergman G; Wong SC; Feldman DN
    J Invasive Cardiol; 2013 Mar; 25(3):132-6. PubMed ID: 23468442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New scoring model (DARSYM score) to predict post-discharge bleeding after successful second-generation drug-eluting stent implantation.
    Honda Y; Yamawaki M; Hirano K; Araki M; Kobayashi N; Sakamoto Y; Mori S; Tsutumi M; Takama T; Tokuda T; Makino K; Shirai S; Ito Y
    Heart Vessels; 2017 Nov; 32(11):1285-1295. PubMed ID: 28560486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis after treatment with drug-eluting coronary stents.
    Uchida Y; Mori F; Ogawa H; Takagi A; Hagiwara N
    J Cardiol; 2010 May; 55(3):362-9. PubMed ID: 20350510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study.
    Gwon HC; Hahn JY; Park KW; Song YB; Chae IH; Lim DS; Han KR; Choi JH; Choi SH; Kang HJ; Koo BK; Ahn T; Yoon JH; Jeong MH; Hong TJ; Chung WY; Choi YJ; Hur SH; Kwon HM; Jeon DW; Kim BO; Park SH; Lee NH; Jeon HK; Jang Y; Kim HS
    Circulation; 2012 Jan; 125(3):505-13. PubMed ID: 22179532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention.
    Patel NJ; Pau D; Nalluri N; Bhatt P; Thakkar B; Kanotra R; Agnihotri K; Ainani N; Patel N; Patel N; Shah S; Kadavath S; Arora S; Sheikh A; Badheka AO; Lafferty J; Alfonso C; Cohen M
    Am J Cardiol; 2016 Oct; 118(8):1150-1157. PubMed ID: 27642112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Choi JW; Ruzyllo W; Religa G; Huang J; Roy K; Dawkins KD; Mohr F
    Circulation; 2014 Jun; 129(23):2388-94. PubMed ID: 24700706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
    J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiplatelet theRapy after Genous EPC-capturing coroNary stenT implantatiOn: the ARGENTO study: a prospective, multicenter registry.
    Cassese S; Galasso G; Sciahbasi A; Scacciatella P; Muçaj A; Piccolo R; D'Anna C; Pangrazi A; Lioy E; Marra S; Piscione F
    Int J Cardiol; 2013 Aug; 167(3):757-61. PubMed ID: 22459371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy.
    Grodzinsky A; Arnold SV; Wang TY; Sharma P; Gosch K; Jones PG; Bhatt DL; Steg PG; McGuire DK; Cohen DJ; Spertus JA; Chhatriwalla AK; Lind M; Graham G; Kosiborod M
    Am Heart J; 2016 Dec; 182():111-118. PubMed ID: 27914490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.